ESC 365 - Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)

ESC Premium Access

Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)

Session: Blood pressure targets in high risk patients: challenges and opportunities

Topic: Pharmacotherapy

Speaker: Doctor M. Pareek (Copenhagen, DK)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 presentation

0 follower

4 more presentations in this session

State of the Art - Blood pressure targets in high risk patients : how low to go?

Speaker: Professor S. MacMahon (Oxford, GB)

Different relationships between blood pressures and clinical events in SPRINT and ACCORD-BP trial

Speaker: Associate Professor D. Shin (Seoul, KR)

Is intensive blood pressure strategy effective and safe in patients with cardiovascular disease? The two sides of the coin

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Blood pressure targets in current guidelines: what's left unanswered?

Speaker: Professor E. Shlyakhto (Saint Petersburg, RU)

Access the full session

Blood pressure targets in high risk patients: challenges and opportunities

Speakers: Doctor M. Pareek, Professor S. MacMahon, Associate Professor D. Shin, Doctor D. Terentes-Printzios, Professor E. Shlyakhto

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources